Abstract:The biosynthetic secretory pathway is comprised of multiple steps, modifications and interactions that form a highly precise pathway of protein trafficking and secretion, that is essential for eukaryotic life. The general outline of this pathway is understood, however the specific mechanisms are still unclear. In the last 15 years there have been vast advancements in technology that enable us to advance our understanding of this complex and subtle pathway. Therefore, based on the strong foundation of work performed over the last 40 years, we can now build another level of understanding, using the new technologies available. The biosynthetic secretory pathway is a high precision process, that involves a number of tightly regulated steps: Protein folding and quality control, cargo selection for Endoplasmic Reticulum (ER) exit, Golgi trafficking, sorting and secretion. When deregulated it causes severe diseases that here we categorise into three main groups of aberrant secretion: decreased, excess and altered secretion. Each of these categories disrupts organ homeostasis differently, effecting extracellular matrix composition, changing signalling events, or damaging the secretory cells due to aberrant intracellular accumulation of secretory proteins. Diseases of aberrant secretion are very common, but despite this, there are few effective therapies. Here we describe ER exit sites (ERES) as key hubs for regulation of the secretory pathway, protein quality control and an integratory hub for signalling within the cell. This review also describes the challenges that will be faced in developing effective therapies, due to the specificity required of potential drug candidates and the crucial need to respect the fine equilibrium of the pathway. The development of novel tools is moving forward, and we can also use these tools to build our understanding of the acute regulation of ERES and protein trafficking. Here we review ERES regulation in context as a therapeutic strategy.

Nonclassical mechanisms of secretory protein in eukaryotic cells

Non-classical Secretory Pathway

Computational Prediction of Secreted Proteins in Gram-Negative Bacteria

Biogenesis of Secretory Proteins in Eukaryotic and Prokaryotic Cells

A Brief Introduction to the Secretion Mechanism in Immunocytes

Protein Secretion In Plants: Conventional And Unconventional Pathways And New Techniques

Unconventional Protein Secretion Dependent on Two Extracellular Vesicles: Exosomes and Ectosomes

Investigation of Non-Classical Secretion of Oxalate Decarboxylase in Bacillus Mojavensis XH1 Mediated by Exopeptide YydF: Mechanism and Application

Trafficking of hormones and trophic factors to secretory and extracellular vesicles: a historical perspective and new hypothesis

[From Endoplasmic Reticulum to Golgi Apparatus: a Secretory Pathway Controlled by Signal Molecules].

Regulation of exosome production and cargo sorting

Secretome analysis: Reading cellular sign language to understand intercellular communication

Exo-Endocytosis: Mechanisms of Drug and Toxin Action

ER exit in physiology and disease

New Signaling Kid on the Block in the Endocrine System: the Role of Extracellular Vesicles

Non-Classical Intercellular Communications: Basic Mechanisms and Roles in Biology and Medicine

Secreted Micrornas: a New Form of Intercellular Communication.

Translational Control of Secretory Proteins in Health and Disease

Exosome and Secretion: Action On?

Exploring the N-terminal role of a heterologous protein in secreting out of Escherichia coli.

Unravelling Secretion in Cryptococcus neoformans: More than One Way to Skin a Cat